Sustained Delivery of an Anti-Glaucoma Drug in Rabbits
Author Information
Author(s): Natarajan Jayaganesh V., Chattopadhyay Sujay, Ang Marcus, Darwitan Anastasia, Foo Selin, Zhen Ma, Koo Magdalene, Wong Tina T., Venkatraman Subbu S.
Primary Institution: School of Materials Science and Engineering, Nanyang Technological University, Singapore
Hypothesis
Can a liposomal formulation of latanoprost provide sustained release and effective intraocular pressure reduction in rabbits?
Conclusion
The liposomal formulation of latanoprost demonstrated sustained intraocular pressure reduction for up to 50 days, outperforming daily eye drop administration.
Supporting Evidence
- The liposomal formulation showed a sustained release of latanoprost in vitro.
- IOP lowering effect was sustained for up to 50 days with a single injection.
- Toxicity and localized inflammation were not observed in any treatment groups.
- The study compared the efficacy of liposomal formulation with conventional eye drops.
Takeaway
This study shows that a special eye drop can keep working for a long time, helping people with eye pressure problems without needing to use it every day.
Methodology
Latanoprost was incorporated into liposomes and tested in 23 rabbits through subconjunctival injection and topical administration.
Potential Biases
Potential bias in animal model selection and treatment administration.
Limitations
The study was conducted in rabbits, and results may not directly translate to humans.
Participant Demographics
Female New Zealand White rabbits.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website